IDXG — INTERPACE BIOSCIENCES, INC.
—
·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1054102 ·
Last close
$6.42
Market Cap
$35.57M
52W High
$7.80
52W Low
$0.77
ADV30
4,903
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 9,131,000 | 5,653,000 | 321,000 | 158,000 | 34,549,000 | 2,688,000 | 11,305,000 |
| Mar 2026 | 9,032,000 | 5,904,000 | 1,123,000 | 721,000 | 33,409,000 | 2,647,000 | 10,327,000 |
| Dec 2025 | 9,224,000 | 6,044,000 | 1,577,000 | 22,657,000 | 33,838,000 | 2,505,000 | 11,476,000 |
| Sep 2025 | 8,756,000 | 5,439,000 | 1,145,000 | 911,000 | 12,036,000 | 1,423,000 | 12,334,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$4,878,000
Investing CF
$-497,000
Financing CF
$-2,931,000
CapEx
$-425,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.74
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-210,084,000
Inventory
$961,000
Receivables
$5,925,000
ST Investments
—
EBIT TTM
$3,226,000
Pretax Income TTM
$3,135,000
Interest Exp TTM
$91,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$36,144,000
EBITDA
$4,649,000
Free Cash Flow
$3,418,750
Enterprise Value
$38,452,312
Total Cash
$2,688,000
Total Debt
$974,000
Shares Out
5,540,181
Trailing EPS
$4.50
Book Value
$0.84
ROE
225.7%
ROA
11.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 38,728,000 | 4,084,000 | 24,575,000 | 33,838,000 | 11,476,000 | 22,362,000 | 5,831,000 |
| Dec 2024 | 46,926,000 | 8,108,000 | 6,702,000 | 14,792,000 | 17,009,000 | -2,217,000 | 4,646,000 |
| Dec 2023 | 40,036,000 | 3,963,000 | 1,954,000 | 13,116,000 | 68,655,000 | -55,539,000 | 3,789,000 |
| Dec 2022 | 31,838,000 | -3,840,000 | -21,958,000 | 15,979,000 | 79,051,000 | -63,072,000 | -7,692,000 |
TTM Snapshot
Revenues TTM
$130,374,000
NetIncome TTM
$-7,698,000
OpCashFlow TTM
$0
Assets (Latest)
$115,906,000
Forward EPS
$-0.15
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ARAY | ACCURAY INC | $35.81M | $0.30 | — |
| QTI | QT IMAGING HOLDINGS, INC. | $35.86M | $2.45 | — |
| MLSS | MILESTONE SCIENTIFIC INC. | $37.15M | $0.41 | — |
| PAVM | PAVmed Inc. | $37.35M | $3.80 | — |
| HRGN | Harvard Apparatus Regenerative Technology, Inc. | $37.80M | $2.15 | — |
News headlines (Yahoo Finance, 1h cache)
Interpace Biosciences Announces First Quarter 2026 Financial and Business Results
2026-05-12 20:06 · Yahoo
Interpace Biosciences Announces Fourth Quarter and Full Year 2025 Financial and Business Results
2026-03-30 20:01 · Yahoo
Interpace Biosciences Announces Reverse Stock Split to Support Proposed Nasdaq Uplisting
2026-08-26 20:05 · Yahoo
Interpace Biosciences Announces Second Quarter 2026 Financial and Business Results
2026-08-10 20:35 · Yahoo
Interpace Biosciences Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure
2026-01-20 14:00 · Yahoo
Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners
2025-12-03 17:12 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.